{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:28:42Z","timestamp":1762900122163},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,13]]},"DOI":"10.7759\/cureus.15002","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T12:49:15Z","timestamp":1620910155000},"source":"Crossref","is-referenced-by-count":2,"title":["Evolution of COVID-19 Pregnancies Treated With Nitazoxanide in a Third-Level Hospital"],"prefix":"10.7759","author":[{"given":"Krista Yazareth","family":"Enr\u00edquez L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Meneses Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"de la Cruz \u00c1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1ngel","family":"L\u00f3pez Esquivel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jazm\u00edn","family":"Meneses Figueroa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Vargas Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Anaya Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofelia Roxana","family":"Sotelo Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Mendoza L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugo","family":"Mendieta Zer\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/752852","article-title":"Pregnancy and susceptibility to infectious diseases","volume":"2013","author":"Sappenfield E","year":"2013","unstructured":"Sappenfield E, Jamieson DJ, Kourtis AP. Pregnancy and susceptibility to infectious diseases. Infect Dis Obstet Gynecol. 2013, 2013:752852. 10.1155\/2013\/752852","journal-title":"Infect Dis Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.03.021","article-title":"Coronavirus disease 2019 (COVID-19) pandemic and pregnancy","volume":"222","author":"Dashraath P","year":"2020","unstructured":"Dashraath P, Wong JLJ, Lim MXK, et al.. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy. Am J Obstet Gynecol. 2020, 222:521-3. 10.1016\/j.ajog.2020.03.021","journal-title":"Am J Obstet Gynecol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1353\/bhm.2002.0022","article-title":"Updating the accounts: global mortality of the 1918-1920 \"Spanish\" influenza pandemic","volume":"76","author":"Johnson NP","year":"2002","unstructured":"Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 \"Spanish\" influenza pandemic. Bull Hist Med. 2002, 76:105-15. 10.1353\/bhm.2002.0022","journal-title":"Bull Hist Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3201\/eid1201.050979","article-title":"1918 Influenza: the mother of all pandemics","volume":"12","author":"Taubenberger JK","year":"2006","unstructured":"Taubenberger JK, Morens DM. 1918 Influenza: the mother of all pandemics. Emerg Infect Dis. 2006, 12:15-22. 10.3201\/eid1201.050979","journal-title":"Emerg Infect Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1919.02610140008002","article-title":"Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases","volume":"72","author":"Harris JW","year":"1919","unstructured":"Harris JW. Influenza occurring in pregnant women: a statistical study of thirteen hundred and fifty cases. JAMA. 1919, 72:978-80. 10.1001\/jama.1919.02610140008002","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(58)90027-9","article-title":"Maternal mortality in the epidemic of Asian influenza, New York City, 1957","volume":"76","author":"Greenberg M","year":"1958","unstructured":"Greenberg M, Jacobziner H, Pakter J, Weisl BA. Maternal mortality in the epidemic of Asian influenza, New York City, 1957. Am J Obstet Gynecol. 1958, 76:897-902. 10.1016\/0002-9378(58)90027-9","journal-title":"Am J Obstet Gynecol"},{"key":"ref7","article-title":"Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008","volume":"57","author":"Fiore AE","year":"2008","unstructured":"Fiore AE, Shay DK, Broder K, et al.. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008, 57:1-60.","journal-title":"MMWR Recomm Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1086\/650460","article-title":"2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia","volume":"50","author":"Hewagama S","year":"2010","unstructured":"Hewagama S, Walker SP, Stuart RL, et al.. 2009 H1N1 influenza A and pregnancy outcomes in Victoria, Australia. Clin Infect Dis. 2010, 50:686-90. 10.1086\/650460","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000218702.92005.bb","article-title":"Hospitalizations with respiratory illness among pregnant women during influenza season","volume":"107","author":"Cox S","year":"2006","unstructured":"Cox S, Posner SF, McPheeters M, Jamieson DJ, Kourtis AP, Meikle S. Hospitalizations with respiratory illness among pregnant women during influenza season. Obstet Gynecol. 2006, 107:1315-22. 10.1097\/01.AOG.0000218702.92005.bb","journal-title":"Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2003.11.019","article-title":"Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome","volume":"191","author":"Wong SF","year":"2004","unstructured":"Wong SF, Chow KM, Leung TN, et al.. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004, 191:292-7. 10.1016\/j.ajog.2003.11.019","journal-title":"Am J Obstet Gynecol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2018.04.005","article-title":"Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature","volume":"52","author":"Alfaraj SH","year":"2019","unstructured":"Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases &amp; review of the literature. J Microbiol Immunol Infect. 2019, 52:501-3. 10.1016\/j.jmii.2018.04.005","journal-title":"J Microbiol Immunol Infect"},{"key":"ref12","unstructured":"Coronavirus Disease (COVID-19). Situation Report - 205 (12 August 2020). (2020). Accessed: March 22, 2021: https:\/\/reliefweb.int\/report\/world\/coronavirus-disease-covid-19-situation-report-205-12-august-2020."},{"key":"ref13","unstructured":"Informe T\u00e9cnico Diario COVID-19 M\u00c9XICO. (2020). Accessed. March 22, 2021: https:\/\/www.gob.mx\/cms\/uploads\/attachment\/file\/571180\/Comunicado_Tecnico_Diario_COVID-19_2020.08.12.pdf."},{"key":"ref14","unstructured":"Johns Hopkins Coronavirus Resource Center. (2021). Accessed. March 22, 2021: https:\/\/coronavirus.jhu.edu."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2016.04.001","article-title":"Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus","volume":"9","author":"Rossignol JF","year":"2016","unstructured":"Rossignol JF. Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus. J Infect Public Health. 2016, 9:227-30. 10.1016\/j.jiph.2016.04.001","journal-title":"J Infect Public Health"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2019.07.003","article-title":"The FDA-approved oral drug nitazoxanide amplifies host antiviral responses and inhibits Ebola virus","volume":"19","author":"Jasenosky LD","year":"2019","unstructured":"Jasenosky LD, Cadena C, Mire CE, et al.. The FDA-approved oral drug nitazoxanide amplifies host antiviral responses and inhibits Ebola virus. iScience. 2019, 19:1279-90. 10.1016\/j.isci.2019.07.003","journal-title":"iScience"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00531","article-title":"Drug repurposing approaches for the treatment of influenza viral infection: reviving old drugs to fight against a long-lived enemy","volume":"10","author":"Pizzorno A","year":"2019","unstructured":"Pizzorno A, Padey B, Terrier O, Rosa-Calatrava M. Drug repurposing approaches for the treatment of influenza viral infection: reviving old drugs to fight against a long-lived enemy. Front Immunol. 2019, 10:531. 10.3389\/fimmu.2019.00531","journal-title":"Front Immunol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s43141-020-00055-5","article-title":"Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?","volume":"18","author":"Mahmoud DB","year":"2020","unstructured":"Mahmoud DB, Shitu Z, Mostafa A. Drug repurposing of nitazoxanide: can it be an effective therapy for COVID-19?. J Genet Eng Biotechnol. 2020, 18:35. 10.1186\/s43141-020-00055-5","journal-title":"J Genet Eng Biotechnol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.13274","article-title":"Nitazoxanide against COVID-19 in three explorative scenarios","volume":"14","author":"Meneses Calder\u00f3n J","year":"2020","unstructured":"Meneses Calder\u00f3n J, Figueroa Flores MDR, Paniagua Coria L, et al.. Nitazoxanide against COVID-19 in three explorative scenarios. J Infect Dev Ctries. 2020, 14:982-6. 10.3855\/jidc.13274","journal-title":"J Infect Dev Ctries"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3892\/wasj.2021.94","article-title":"Nitazoxanide as prophylactic use to reduce the intensity of COVID-19 outbreaks in health personnel","volume":"3","author":"Mendieta Zer\u00f3n H","year":"2021","unstructured":"Mendieta Zer\u00f3n H, Meneses Calder\u00f3n J, Paniagua Coria L, et al.. Nitazoxanide as prophylactic use to reduce the intensity of COVID-19 outbreaks in health personnel. World Acad Sci J. 2021, 3:1-8. 10.3892\/wasj.2021.94","journal-title":"World Acad Sci J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.0c00478","article-title":"Therapeutic potential of nitazoxanide: an appropriate choice for repurposing versus SARS-CoV-2? [Online ahead of print]","author":"Stachulski AV","year":"2020","unstructured":"Stachulski AV, Taujanskas J, Pate SL, et al.. Therapeutic potential of nitazoxanide: an appropriate choice for repurposing versus SARS-CoV-2? [Online ahead of print]. ACS Infect Dis. 2020, 10.1021\/acsinfecdis.0c00478","journal-title":"ACS Infect Dis"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173748","article-title":"A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19","volume":"891","author":"Lokhande AS","year":"2021","unstructured":"Lokhande AS, Devarajan PV. A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19. Eur J Pharmacol. 2021, 891:173748. 10.1016\/j.ejphar.2020.173748","journal-title":"Eur J Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14619","article-title":"Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis","volume":"87","author":"Rajoli RKR","year":"2021","unstructured":"Rajoli RKR, Pertinez H, Arshad U, et al.. Dose prediction for repurposing nitazoxanide in SARS-CoV-2 treatment or chemoprophylaxis. Br J Clin Pharmacol. 2021, 87:2078-8. 10.1111\/bcp.14619","journal-title":"Br J Clin Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp0904572","article-title":"Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus","volume":"361","author":"Trifonov V","year":"2009","unstructured":"Trifonov V, Khiabanian H, Rabadan R. Geographic dependence, surveillance, and origins of the 2009 influenza A (H1N1) virus. N Engl J Med. 2009, 361:115-9. 10.1056\/NEJMp0904572","journal-title":"N Engl J Med"},{"key":"ref25","unstructured":"Plan nacional de preparaci\u00f3n y respuesta ante una Pandemia de Influenza. (2006). Accessed. March 22, 2021: http:\/\/www.cenaprece.salud.gob.mx\/programas\/interior\/emergencias\/descargas\/pdf\/Plan_Nacional_Influenza.pdf."},{"key":"ref26","unstructured":"Pandemic influenza A (H1N1). (2021). Accessed. March 22, 2021: https:\/\/www.who.int\/csr\/resources\/publications\/swineflu\/h1n1_donor_032011.pdf."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30360-3","article-title":"Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records","volume":"395","author":"Chen H","year":"2020","unstructured":"Chen H, Guo J, Wang C, et al.. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020, 395:809-15. 10.1016\/S0140-6736(20)30360-3","journal-title":"Lancet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.21037\/tp.2020.02.06","article-title":"Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia","volume":"9","author":"Zhu H","year":"2020","unstructured":"Zhu H, Wang L, Fang C, et al.. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020, 9:51-60. 10.21037\/tp.2020.02.06","journal-title":"Transl Pediatr"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100107","article-title":"Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a\u00a0systematic review and meta-analysis","volume":"2","author":"Di Mascio D","year":"2020","unstructured":"Di Mascio D, Khalil A, Saccone G, et al.. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a\u00a0systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020, 2:100107. 10.1016\/j.ajogmf.2020.100107","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0901-SA","article-title":"An analysis of 38 pregnant women with COVID-19, their newborn Infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes","volume":"144","author":"Schwartz DA","year":"2020","unstructured":"Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn Infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020, 144:799-805. 10.5858\/arpa.2020-0901-SA","journal-title":"Arch Pathol Lab Med"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13867","article-title":"Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies","volume":"99","author":"Zaigham M","year":"2020","unstructured":"Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020, 99:823-9. 10.1111\/aogs.13867","journal-title":"Acta Obstet Gynecol Scand"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajogmf.2020.100118","article-title":"Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals","volume":"2","author":"Breslin N","year":"2020","unstructured":"Breslin N, Baptiste C, Gyamfi-Bannerman C, et al.. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM. 2020, 2:100118. 10.1016\/j.ajogmf.2020.100118","journal-title":"Am J Obstet Gynecol MFM"},{"key":"ref33","unstructured":"Informes Semanales para la Vigilancia Epidemiol\u00f3gica de Muertes Maternas 2020. (2020). Accessed. March 22, 2021: https:\/\/www.gob.mx\/salud\/documentos\/informes-semanales-para-la-vigilancia-epidemiologica-de-muertes-maternas-2020.."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-03772-y","article-title":"The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis","volume":"21","author":"Qeadan F","year":"2021","unstructured":"Qeadan F, Mensah NA, Tingey B, Stanford JB. The risk of clinical complications and death among pregnant women with COVID-19 in the Cerner COVID-19 cohort: a retrospective analysis. BMC Pregnancy Childbirth. 2021, 21:305. 10.1186\/s12884-021-03772-y","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s42399-021-00915-2","article-title":"COVID-19 and pregnancy: risk, symptoms, diagnosis, and treatment [Online ahead of print]","author":"Hapshy V","year":"2021","unstructured":"Hapshy V, Aziz D, Kahar P, Khanna D, Johnson KE, Parmar MS. COVID-19 and pregnancy: risk, symptoms, diagnosis, and treatment [Online ahead of print]. SN Compr Clin Med. 2021, 10.1007\/s42399-021-00915-2","journal-title":"SN Compr Clin Med"},{"key":"ref36","unstructured":"Sistema de indicadores. Boletines semanales de muerte materna. (2021). Accessed. March 22, 2021: https:\/\/omm.org.mx\/sistema-de-indicadores\/boletines\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/55886-evolution-of-covid-19-pregnancies-treated-with-nitazoxanide-in-a-third-level-hospital","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:28:25Z","timestamp":1707506905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/55886-evolution-of-covid-19-pregnancies-treated-with-nitazoxanide-in-a-third-level-hospital"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,13]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.15002","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5,13]]}}}